Protein kinase CK2: a potential therapeutic target for diverse human diseases
CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of
substrates, controls several signaling pathways, and is implicated in a plethora of human …
substrates, controls several signaling pathways, and is implicated in a plethora of human …
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
Protein kinases have grown over the past few years as a crucial target for different cancer
types. With the multifactorial nature of cancer, and the fast development of drug resistance …
types. With the multifactorial nature of cancer, and the fast development of drug resistance …
Strategies of targeting CK2 in drug discovery: challenges, opportunities, and emerging prospects
Y Chen, Y Wang, J Wang, Z Zhou, S Cao… - Journal of Medicinal …, 2023 - ACS Publications
CK2 (casein kinase 2) is a serine/threonine protein kinase that is ubiquitous in eukaryotic
cells and plays important roles in a variety of cellular functions, including cell growth …
cells and plays important roles in a variety of cellular functions, including cell growth …
Development of a potent and selective chemical probe for the pleiotropic kinase CK2
Building on the pyrazolopyrimidine CK2 (casein kinase 2) inhibitor scaffold, we designed a
small targeted library. Through comprehensive evaluation of inhibitor selectivity, we …
small targeted library. Through comprehensive evaluation of inhibitor selectivity, we …
Engine shutdown: migrastatic strategies and prevention of metastases
M Raudenská, K Petrláková, T Juriňáková, JL Fialová… - Trends in Cancer, 2023 - cell.com
Most cancer-related deaths among patients with solid tumors are caused by metastases.
Migrastatic strategies represent a unique therapeutic approach to prevent all forms of cancer …
Migrastatic strategies represent a unique therapeutic approach to prevent all forms of cancer …
Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth
T Oshima, Y Niwa, K Kuwata, A Srivastava, T Hyoda… - Science …, 2019 - science.org
Compounds targeting the circadian clock have been identified as potential treatments for
clock-related diseases, including cancer. Our cell-based phenotypic screen revealed …
clock-related diseases, including cancer. Our cell-based phenotypic screen revealed …
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy–potential clinical relevance
Background Protein kinase CK2 inhibition has long been considered as an attractive anti-
cancer strategy based on the following considerations: CK2 is a pro-survival kinase, it is …
cancer strategy based on the following considerations: CK2 is a pro-survival kinase, it is …
[HTML][HTML] Melanoma therapeutics: a literature review
PK Dhanyamraju, TN Patel - Journal of biomedical research, 2022 - ncbi.nlm.nih.gov
Melanoma is a relentless type of skin cancer which involves myriad signaling pathways
which regulate many cellular processes. This makes melanoma difficult to treat, especially …
which regulate many cellular processes. This makes melanoma difficult to treat, especially …
Anticancer and antibacterial activities of embelin: Micro and nano aspects
M Alavi, F Martinez, DR Delgado… - Micro Nano Bio …, 2022 - mnba-journal.com
There are some reported anticancer and antibacterial effects for embelin, although, it's poor
aqueous solubility and bioavailability are main hindrance to apply embelin in therapeutics …
aqueous solubility and bioavailability are main hindrance to apply embelin in therapeutics …
SMAD4 prevents flow induced arteriovenous malformations by inhibiting casein kinase 2
Background: Hereditary hemorrhagic telangiectasia (HHT) is an inherited vascular disorder
that causes arteriovenous malformations (AVMs). Mutations in the genes encoding Endoglin …
that causes arteriovenous malformations (AVMs). Mutations in the genes encoding Endoglin …